|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 383.40 INR | -1.30% |
|
-2.91% | -6.91% |
| 07/03 | Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited | CI |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 |
Chart calendar Aarti Drugs Limited
Upcoming events on Aarti Drugs Limited
| 18/07/2025 | Board of Directors Meeting | 12:00 pm |
| 18/07/2025 | Earnings release - Q1 2026 | Day |
| 21/07/2025 | Earnings presentation | 11:00 am |
| 24/09/2025 | Présentation aux Actionnaires / Analystes | 11:00 am |
| 24/09/2025 | Annual General Meeting | 11:00 am |
| 07/11/2025 | Earnings release - Q2 2026 | |
| 07/11/2025 | Board of Directors Meeting | 12:00 pm |
| 10/11/2025 | Earnings presentation | 11:30 am |
| 03/02/2026 | Earnings release - Q3 2026 | |
| 03/02/2026 | Board of Directors Meeting | Day |
| 04/02/2026 | Earnings presentation | 11:00 am |
| 09/02/2026 | Ex-dividend date - 2 INR | 10:30 am |
| 11/03/2026 | Présentation aux Actionnaires / Analystes | 10:00 am |
| 15/05/2026 | Board of Directors Meeting | Day |
| 15/05/2026 | Earnings release - Q4 2026 |
Past events on Aarti Drugs Limited
Annual results
| Fiscal Period | March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 27 161 26 590 2.15% | 25 286 26 118 -3.19% | 23 870 23 031 3.64% | 26 066 | 29 472 | 33 182 |
|
EBITDA Million INR | Released Forecast Spread | 3 056 3 027 0.97% | 3 165 3 186 -0.67% | 2 871 2 626 9.31% | 3 206 | 4 008 | 4 645 |
|
EBIT Million INR | Released Forecast Spread | 2 553 2 438 4.71% | 2 650 2 583 2.6% | 2 313 2 078 11.3% | 2 569 | 3 266 | 3 843 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 242 2 168 3.42% | 2 355 2 306 2.14% | 2 118 1 883 12.46% | 2 306 | 2 964 | 3 554 |
|
Net income Million INR | Released Forecast Spread | 1 663 1 633 1.84% | 1 714 1 730 -0.91% | 1 682 1 412 19.09% | 1 822 | 2 253 | 2 666 |
|
EPS INR | Released Forecast Spread | 18,0 17,6 1.91% | 18,6 18,7 -0.75% | 18,4 15,5 18.39% | 20,0 | 24,7 | 29,2 |
| Announcement Date | 29/04/23 | 03/05/24 | 06/05/25 | - |
Quarterly results
| Fiscal Period | March | 2026 Q1 | 2026 Q2 |
|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 6 395 | |
|
EBITDA Million INR | Released Forecast Spread | 812 | |
|
Net income Million INR | Released Forecast Spread | 539 | 445 |
|
EPS INR | Released Forecast Spread | 4,90 | |
| Announcement Date | 18/07/25 | - |
| 12/05/2025 |  | Ex-dividend date - 3.92 EUR | 09:30 am |
| 12/05/2025 | | Earnings release - Annual 2025 | 09:30 am |
| 12/05/2025 | | Earnings presentation | 12:30 pm |
| 12/05/2025 | | Earnings presentation | 11:00 am |
| 12/05/2025 | | Earnings release - Q1 2025 | |
| 12/05/2025 | | Earnings presentation | 06:00 pm |
| 13/05/2025 | | Earnings release - Q1 2025 | 11:00 am |
| 13/05/2025 | | Earnings presentation | 05:30 pm |
| 13/05/2025 | | Earnings presentation | 07:00 am |
| 13/05/2025 | | Board of Directors Meeting | 01:30 pm |
Past sector events for Aarti Drugs Limited
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 524348 Stock
- Calendar Aarti Drugs Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition